Pulmonx Corp Stock Market Value
| LUNG Stock | USD 6.45 0.15 2.38% |
| Symbol | Pulmonx |
Pulmonx Corp Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.154 | Return On Assets (0.20) | Return On Equity (0.52) |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pulmonx Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pulmonx Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pulmonx Corp.
| 06/03/2024 |
| 11/30/2024 |
If you would invest 0.00 in Pulmonx Corp on June 3, 2024 and sell it all today you would earn a total of 0.00 from holding Pulmonx Corp or generate 0.0% return on investment in Pulmonx Corp over 180 days. Pulmonx Corp is related to or competes with Iradimed, Orthofix Medical, Neuropace, Integer Holdings, CONMED, Orthopediatrics Corp, and Si Bone. Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obst... More
Pulmonx Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pulmonx Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pulmonx Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 20.44 | |||
| Value At Risk | (6.89) | |||
| Potential Upside | 8.44 |
Pulmonx Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pulmonx Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pulmonx Corp's standard deviation. In reality, there are many statistical measures that can use Pulmonx Corp historical prices to predict the future Pulmonx Corp's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | (0.07) |
Pulmonx Corp Backtested Returns
At this point, Pulmonx Corp is slightly risky. Pulmonx Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.0177, which implies the firm had a 0.0177% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Pulmonx Corp, which you can use to evaluate the volatility of the company. Please check Pulmonx Corp's Variance of 19.05, risk adjusted performance of (0.01), and Coefficient Of Variation of (3,444) to confirm if the risk estimate we provide is consistent with the expected return of 0.0748%. Pulmonx Corp has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 1.89, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pulmonx Corp will likely underperform. Pulmonx Corp right now holds a risk of 4.23%. Please check Pulmonx Corp potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Pulmonx Corp will be following its historical price patterns.
Auto-correlation | -0.62 |
Very good reverse predictability
Pulmonx Corp has very good reverse predictability. Overlapping area represents the amount of predictability between Pulmonx Corp time series from 3rd of June 2024 to 1st of September 2024 and 1st of September 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pulmonx Corp price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current Pulmonx Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.59 |
Pulmonx Corp lagged returns against current returns
Autocorrelation, which is Pulmonx Corp stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pulmonx Corp's stock expected returns. We can calculate the autocorrelation of Pulmonx Corp returns to help us make a trade decision. For example, suppose you find that Pulmonx Corp has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pulmonx Corp regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pulmonx Corp stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pulmonx Corp stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pulmonx Corp stock over time.
Current vs Lagged Prices |
| Timeline |
Pulmonx Corp Lagged Returns
When evaluating Pulmonx Corp's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pulmonx Corp stock have on its future price. Pulmonx Corp autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pulmonx Corp autocorrelation shows the relationship between Pulmonx Corp stock current value and its past values and can show if there is a momentum factor associated with investing in Pulmonx Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:Check out Pulmonx Corp Correlation, Pulmonx Corp Volatility and Pulmonx Corp Alpha and Beta module to complement your research on Pulmonx Corp. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Pulmonx Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.